Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 90501 - 90520 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (L01EL01) ibrutinib (adm: O) | Imbruvica | Cap/Caps. Orl 140 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | JAN |
| Canada | (L01EL02) acalabrutinib (adm: O) | Calquence | Cap/Caps. Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AZE |
| Canada | (L01EL03) zanubrutinib (adm: O) | Brukinsa | Cap/Caps. Orl 80 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Waldenstrom Macroglobulinemia | BGN |
| Canada | (L01EL03) zanubrutinib (adm: O) | Brukinsa | Tab/Co. Orl 160 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Waldenstrom Macroglobulinemia | BGN |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 10 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 12 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 14 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 20 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 24 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 4 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX08) lenvatinib (adm: O) | Lenvima | Cap/Caps. Orl 8 mg/dose,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EIS |
| Canada | (L01EX09) nintedanib (adm: O) | Ofev | Cap/Caps. Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis;Lung Diseases, Interstitial;Pulmonary Fibrosis;Scleroderma, Systemic | BOE |
| Canada | (L01EX09) nintedanib (adm: O) | Ofev | Cap/Caps. Orl 150 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis;Lung Diseases, Interstitial;Pulmonary Fibrosis;Scleroderma, Systemic | BOE |
| Canada | (L01EX10) midostaurin (adm: O) | Rydapt | Cap/Caps. Orl 25 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NVR |
| Canada | (L01EX12) larotrectinib (adm: O) | Vitrakvi | Liq/Liq. Orl 20 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAY |
| Canada | (L01EX12) larotrectinib (adm: O) | Vitrakvi | Cap/Caps. Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAY |
| Canada | (L01EX12) larotrectinib (adm: O) | Vitrakvi | Cap/Caps. Orl 25 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAY |
| Canada | (L01EX14) entrectinib (adm: O) | Rozlytrek | Cap/Caps. Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | HLR |
| Canada | (L01EX14) entrectinib (adm: O) | Rozlytrek | Cap/Caps. Orl 200 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | HLR |
| Canada | (L01EX19) ripretinib (adm: O) | Qinlock | Tab/Co. Orl 50 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | MDP |
Pages
